FindTrial
Sign In

A multi-center clinical study for treatment of acute paraquat poisoning by enhanced blood purification

A multi-center clinical study for treatment of acute paraquat poisoning by enhanced blood purification

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900023292
Enrollment
Unknown
Registered
2019-05-21
Start date
2019-10-01
Completion date
Unknown
Last updated
2019-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute paraquat poisoning

Interventions

enhanced blood purification group:enhanced blood purification
enhanced hemoperfusion group:enhanced hemoperfusion
continuous venovenous hemoftltration group :continuous venovenous hemoftltration
drug therapy group: drug therapy

Sponsors

The Second Affiliated Hospital of Kunming Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to No maximum

Inclusion criteria

Inclusion criteria: 1 Aged 14 years and above; 2 A clear history of paraquat exposure; 3 Come to the emergency department within 48 hours of poisoning; 4 Symptoms of paraquat poisoning; 5 Patients and their families signed a written informed consent.

Exclusion criteria

Exclusion criteria: 1 Mixed poison poisoning; 2 pregnancy; 3 Suffering from chronic lung disease and chronic liver and kidney damage; 4 loss to follow-up.

Design outcomes

Primary

MeasureTime frame
death rate at 90-day after poisoning;—

Secondary

MeasureTime frame
Death rate at 15-day after poisoning;blood gas analysis;live function;renal function;injury of lungs;—

Countries

China

Contacts

Public ContactChen Anbao

The Second Affiliated Hospital of Kunming Medical University

yiyeecab@sina.com+86 13987659345

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026